Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.

  • 1 December 1982
    • journal article
    • Vol. 66  (12) , 2095-6
Abstract
No abstract available

This publication has 0 references indexed in Scilit: